Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

RSS icon

JACC: Same-day PCI discharge vs. overnight cuts costs in half

Same-day discharge after uncomplicated transradial PCI, in addition to a bolus-only abciximab regimen, reduced medical costs by 50 percent, according to the results of the EASY trial published in the October issue of the Journal of the American College of Cardiology: Cardiovascualar Interventions.

Z-Medica's QuikClot to be distributed in Nordic countries

Vingmed and Mediplast, two Swedish medical device distributors, will have the right to distribute Z-Medicas QuikClot portfolio of hemostatic agents throughout Sweden, Denmark and Norway.

FDA (finally) permits Medtronic to trial CoreValve

In a long-awaited decision, the FDA has granted Medtronic conditional approval for its investigational device exemption application, and the clinical trial is designed to evaluate the safety and efficacy of the CoreValve system for transcatheter aortic valve implantation (TAVI).

JACC: Taking aspirin before ACS increases MI risk, but not death

Taking aspirin prior to acute coronary syndrome (ACS) increases the risk of coronary disease and recurrent MI and is linked to more comorbidities, but not death, according to a study published in the Oct. 19 issue of the Journal of the American College of Cardiology.

JACC: Left main PCI = higher revascularization, similar death rates

Stenting left main coronary artery disease (CAD) produced similar outcomes to CABG, including a low stent thrombosis rate. However, PCI, with bare-metal or drug-eluting stents, resulted in more revascularization, according to a Korean study published in the Oct. 19 issue of the Journal of the American College of Cardiology.

JAMA: Less variability, use of blood transfusions could improve CABG outcomes

Allogeneic blood transfusions during CABG are associated with increased morbidity and mortality rates, but variation in their use makes it difficult to implement improvements. Additionally, restricting transfusions reduces death and severe illness, according to two studies in the Oct. 13 issue of the Journal of the American Medical Association.

Z-Medica, Romed to distribute QuikClot portfolio in Belgium

Z-Medica and Romed have entered into a distribution agreement that will allow Romed to distribute and sell Z-Medicas QuikClot hemostatic agents throughout Belgium.

Baltimore hospital hit with 104 lawsuits alleging unnecessary stenting

The St. Joseph Medical Center in Baltimore has been slapped with 104 lawsuits, all which accuse Mark Midei, MD, a former cardiologist at the facility, of committing medical negligence after it was found that he may have implanted hundreds of unnecessary stents in cardiac patients.

Displaying 2345 - 2352 of 2712

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.